Most importantly, the presence of significant CD28 down-regulation identified IPF subjects who had particularly poor clinical outcomes, analogous to observations in other patient populations with chronic immunologic diseases [20]–[23], [32]–[34]. Here, CD28 is linked to idiopathic pulmonary fibrosis.